Clinical Trials

Phase 2 Active not recruiting

Lung Neoplasms, Small Cell Lung Carcinoma

NCT03728361 2025-12-18

Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advanced Neuroendocrine Cancer

55 enrolled

EndocrineNETThoracic

Lung Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors, Small Cell Lung Carcinoma

NCT03672773 2025-11-10

TRIO-US L-07

Phase 2 Active not recruiting

35 enrolled

Phase 2 Active not recruiting

Small Cell Lung Carcinoma

NCT01638546 2025-10-29

Temozolomide With or Without Veliparib in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer

97 enrolled 12 charts

Small Cell Lung Carcinoma

NCT00080938 2023-06-29

Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer

26 enrolled 8 charts

Adenocarcinoma of Lung, Brain Neoplasms, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

NCT02605811 2019-03-28

Temozolomide in Preventing Brain Metastases in Small Cell Lung Cancer

Phase 2 Unknown

426 enrolled

Brain Neoplasms, Carcinoma, Small Cell Lung Carcinoma

NCT02477813 2018-11-13

TeRes

6 enrolled

Small Cell Lung Cancer Recurrent

NCT00266812 2017-06-08

Safety and Tolerability of Low-Dose Temozolomide During Whole Brain Radiation in Patients With Cerebral Metastases From Non-Small-Cell Lung Cancer (Study P04071)(TERMINATED)

35 enrolled 7 charts

Carcinoma, Non-Small-Cell Lung

NCT00632203 2017-06-07

Study of Maintenance Temozolomide Versus Observation in Stable or Responding Stage III/IV Non-Small Cell Lung Cancer Patients (Study P05146)

53 enrolled 10 charts

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Carcinoma, Large Cell

NCT00034697 2017-05-23

Study of Temozolomide in the Treatment of Brain Metastasis From Non-small-cell Lung Cancer (Study P02143)

24 enrolled

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT00076856 2017-05-09

Temozolomide for Treatment of Brain Metastases From Non-Small Cell Lung Cancer (Study P03247)

95 enrolled

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT00831545 2017-05-09

Study to Evaluate the Efficacy and Safety of Temozolomide in Subjects With Brain Metastases of Either Malignant Melanoma, Breast, or Non-small Cell Lung Cancer (P02064)

BreastDermatologicThoracic

162 enrolled

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Melanoma

NCT02972320 2016-11-23

Extensive Stage Sclc Patients Who Were Benefit From First-line Treatment Accept Temozolomide Maintain Therapeutic

Phase 2 Unknown

60 enrolled

Extensive Stage Small Cell Lung Cancer

NCT00740636 2016-08-01

Temozolomide for Relapsed Sensitive or Refractory Small Cell Lung Cancer

92 enrolled 7 charts

Lung Neoplasms

NCT02133677 2014-05-08

A Phase II Multi-center Pilot Study of Concurrent Temozolomide and Whole Brain Irradiation in Lung Cancer and Breast Cancer Patients With Brain Metastases

Phase 2 Unknown

24 enrolled

Lung Neoplasms

NCT00006877 2014-01-08

Temozolomide in Treating Patients With Metastatic Non-small Cell Lung Cancer

30 enrolled

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00003062 2012-07-02

Temozolomide in Patients With Progressive or Recurrent Non-small Cell Lung Cancer

70 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00238251 2012-06-05

Radiation Therapy Combined With Either Gefitinib or Temozolomide in Pats With NSCLC and Brain Metastases

59 enrolled